These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 15306578

  • 1. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
    Leung WK, Lin SR, Ching JY, To KF, Ng EK, Chan FK, Lau JY, Sung JJ.
    Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578
    [Abstract] [Full Text] [Related]

  • 2. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
    Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS, China Gastric Cancer Study Group.
    JAMA; 2004 Jan 14; 291(2):187-94. PubMed ID: 14722144
    [Abstract] [Full Text] [Related]

  • 3. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.
    Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, Snel P, Goldfain D, Kolkman JJ, Festen HP, Dent J, Zeitoun P, Havu N, Lamm M, Walan A.
    Gut; 2004 Jan 14; 53(1):12-20. PubMed ID: 14684569
    [Abstract] [Full Text] [Related]

  • 4. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
    You WC, Brown LM, Zhang L, Li JY, Jin ML, Chang YS, Ma JL, Pan KF, Liu WD, Hu Y, Crystal-Mansour S, Pee D, Blot WJ, Fraumeni JF, Xu GW, Gail MH.
    J Natl Cancer Inst; 2006 Jul 19; 98(14):974-83. PubMed ID: 16849680
    [Abstract] [Full Text] [Related]

  • 5. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
    Piazuelo MB, Bravo LE, Mera RM, Camargo MC, Bravo JC, Delgado AG, Washington MK, Rosero A, Garcia LS, Realpe JL, Cifuentes SP, Morgan DR, Peek RM, Correa P, Wilson KT.
    Gastroenterology; 2021 Mar 19; 160(4):1106-1117.e3. PubMed ID: 33220252
    [Abstract] [Full Text] [Related]

  • 6. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
    Liu D, He Q, Liu C.
    J Gastroenterol Hepatol; 2010 Apr 19; 25(4):795-9. PubMed ID: 20492336
    [Abstract] [Full Text] [Related]

  • 7. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
    Liu KS, Wong IO, Leung WK.
    World J Gastroenterol; 2016 Jan 21; 22(3):1311-20. PubMed ID: 26811668
    [Abstract] [Full Text] [Related]

  • 8. Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial.
    Mera RM, Bravo LE, Camargo MC, Bravo JC, Delgado AG, Romero-Gallo J, Yepez MC, Realpe JL, Schneider BG, Morgan DR, Peek RM, Correa P, Wilson KT, Piazuelo MB.
    Gut; 2018 Jul 21; 67(7):1239-1246. PubMed ID: 28647684
    [Abstract] [Full Text] [Related]

  • 9. Precancerous conditions after H. pylori eradication: a randomized double blind study in first degree relatives of gastric cancer patients.
    Massarrat S, Haj-Sheykholeslami A, Mohamadkhani A, Zendehdel N, Rakhshani N, Stolte M, Mirzaei M, Saliminejhad M, Saeidi S, Shahidi M.
    Arch Iran Med; 2012 Nov 21; 15(11):664-9. PubMed ID: 23102241
    [Abstract] [Full Text] [Related]

  • 10. Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.
    Giuliani A, Spada S, Corona M, Demoro M, Di Bari M, Ricciardulli T, Galati G, Caporale A, Tocchi A, Angelico F.
    J Exp Clin Cancer Res; 2003 Sep 21; 22(3):371-8. PubMed ID: 14582693
    [Abstract] [Full Text] [Related]

  • 11. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial).
    Aumpan N, Vilaichone RK, Pornthisarn B, Chonprasertsuk S, Siramolpiwat S, Bhanthumkomol P, Nunanan P, Issariyakulkarn N, Ratana-Amornpin S, Miftahussurur M, Mahachai V, Yamaoka Y.
    PLoS One; 2021 Sep 21; 16(8):e0255601. PubMed ID: 34379655
    [Abstract] [Full Text] [Related]

  • 12. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study.
    Sung JJ, Lin SR, Ching JY, Zhou LY, To KF, Wang RT, Leung WK, Ng EK, Lau JY, Lee YT, Yeung CK, Chao W, Chung SC.
    Gastroenterology; 2000 Jul 21; 119(1):7-14. PubMed ID: 10889149
    [Abstract] [Full Text] [Related]

  • 13. K-ras mutations and cell kinetics in Helicobacter pylori associated gastric intestinal metaplasia: a comparison before and after eradication in patients with chronic gastritis and gastric cancer.
    Watari J, Tanaka A, Tanabe H, Sato R, Moriichi K, Zaky A, Okamoto K, Maemoto A, Fujiya M, Ashida T, Das KM, Kohgo Y.
    J Clin Pathol; 2007 Aug 21; 60(8):921-6. PubMed ID: 16997920
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
    Wong BC, Zhang L, Ma JL, Pan KF, Li JY, Shen L, Liu WD, Feng GS, Zhang XD, Li J, Lu AP, Xia HH, Lam S, You WC.
    Gut; 2012 Jun 21; 61(6):812-8. PubMed ID: 21917649
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
    Kyzekova J, Mour J.
    Hepatogastroenterology; 1999 Jun 21; 46(27):2048-56. PubMed ID: 10430396
    [Abstract] [Full Text] [Related]

  • 18. Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China.
    Zhang Y, Pan KF, Zhang L, Ma JL, Zhou T, Li JY, Shen L, You WC.
    Carcinogenesis; 2015 Dec 21; 36(12):1572-9. PubMed ID: 26449252
    [Abstract] [Full Text] [Related]

  • 19. H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole.
    Yang HB, Sheu BS, Wang ST, Cheng HC, Chang WL, Chen WY.
    Am J Gastroenterol; 2009 Jul 21; 104(7):1642-9. PubMed ID: 19436275
    [Abstract] [Full Text] [Related]

  • 20. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
    De Leest HT, Steen KS, Bloemena E, Lems WF, Kuipers EJ, Van de Laar MA, Bijlsma JW, Janssen M, Houben HH, Kostense PJ, Boers M, Dijkmans BA.
    J Clin Gastroenterol; 2009 Feb 21; 43(2):140-6. PubMed ID: 18797408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.